AI-based digital stethoscope to identify structural heart murmurs launched
Click Here to Manage Email Alerts
Eko announced the launch of a digital stethoscope that includes the use of artificial intelligence to identify structural heart murmurs.
The technology behind the digital stethoscope (Sensora) received FDA clearance in July 2022, according to the company.
Detection of structural heart murmurs via the digital stethoscope can help primary care and urgent care providers identify valvular heart disease, which can lead to HF, stroke, blood clots or death if not diagnosed, and more than half of older adults with valvular heart disease do not get it detected, the company stated in a press release.
“Our vision for Sensora is to make cardiovascular disease detection simple and accurate in frontline care settings like primary care and urgent care,” Connor Landgraf, co-founder and CEO of Eko, said in the release. “During a routine physical exam, patients can now have access to advanced structural murmur detection and arrhythmia assessment by their primary care physician in seconds, making early intervention possible for millions of patients with silent cardiovascular disease. We are making the world’s most universal medical exam objective and accurate.”
The system also includes care pathway analytics, which identifies and can help improve downstream care gaps of patients with valvular heart disease, according to the release.
“The primary care setting is a patient’s first line of defense for identifying and diagnosing heart disease,” John Chorba, MD, assistant professor in residence, division of cardiology, Zuckerberg San Francisco General Hospital and department of medicine, University of California, San Francisco, said in the release. “However, we know from clinical evidence that detection rates are low. The Sensora platform promises to better serve patients by increasing the accuracy and consistency of structural murmur identification and improving patients’ lives by getting them into treatment earlier.”